Mayo Clinic is firmly committed to patient safety. In order to protect all of our patients and staff, Mayo Clinic is limiting the number of visitors on our campuses while there is a threat of COVID-19 transmission. Please know that limiting the number of visitors is temporary and is to safeguard the health of all who come to Mayo Clinic. We will also be screening patients and those accompanying them at entry to our outpatient clinics and hospitals. Please visit our website for further details regarding patient scheduling. Mohamed Kharfan-Dabaja, M.D. is a hematologist and oncologist in the Blood and Marrow Transplant and Cellular Therapy (CAR-T) programs at Mayo Clinic’s campus in Jacksonville, Florida. He specializes in the treatment of acute myelogenous leukemia, aplastic anemia, chronic lymphocytic leukemia, diffuse large b-cell lymphoma, Hodgkin’s lymphoma, and Non-Hodgkin’s lymphoma.

Dr. Kharfan-Dabaja has published more than 200 manuscripts, 15 book chapters, and has presented his work at many international scientific forums. He is certified by the American Board of Internal Medicine with specialties in internal medicine, hematology and medical oncology.